Capricor Therapeutics Current Assets

Capricor Therapeutics (CAPR) currently reports a current assets of $240B as of June 2026. That compares with $120M in the prior-year period — up 194965.4% year over year. Use the charts on this page to explore Capricor Therapeutics's current assets history and peer comparisons.

Capricor Therapeutics's current assets increased from $120M to $240B — a 194965.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Capricor Therapeutics reported $240B in current assets as of June 2026. That compares with $120M in the prior-year period — up 194965.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $240B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Capricor Therapeutics, and consider following CAPR for alerts when major investors trade the stock.

Capricor Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $240B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CAPR with unrelated industries.